fenofibrate has been researched along with Carbohydrate Inducible Hyperlipemia in 23 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
| Excerpt | Relevance | Reference |
|---|---|---|
| "In patients with type IIa or IIb dyslipidemia, TC decreased (-14." | 1.31 | Efficacy and tolerability of a "suprabioavailable" formulation of fenofibrate in patients with dyslipidemia: a pooled analysis of two open-label trials. ( Callaghan, DJ; Ramjattan, BR; Theiss, U, 2002) |
| "Fenofibrate (300 mg/day) was then given for 2 periods of 2 months, each separated by a 2-month period in which only the dietary treatment was continued." | 1.27 | Variations in lipids and proteins of lipoproteins by fenofibrate in some hyperlipoproteinaemic states. ( Avogaro, P; Belussi, F; Bittolo Bon, G; Cazzolato, G; Pontoglio, E, 1983) |
| "Fenofibrate was also found to normalize platelet aggregation in patients with type IIb HLP." | 1.26 | [Pharmacology of fenofibrate (author's transl)]. ( Kritchevsky, D, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (78.26) | 18.7374 |
| 1990's | 2 (8.70) | 18.2507 |
| 2000's | 3 (13.04) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Soubrier, M | 1 |
| Dubost, JJ | 1 |
| Thiéblot, P | 1 |
| Ristori, JM | 1 |
| Ramjattan, BR | 1 |
| Callaghan, DJ | 1 |
| Theiss, U | 1 |
| Noda, K | 1 |
| Zhang, B | 1 |
| Uehara, Y | 1 |
| Miura, S | 1 |
| Matsunaga, A | 1 |
| Saku, K | 1 |
| Sznajd, J | 1 |
| Magdoń, M | 1 |
| Idzior, B | 1 |
| Konarska, R | 1 |
| Malczewska, M | 1 |
| Czarnecka, H | 1 |
| Sznajderman, M | 2 |
| Sommariva, D | 1 |
| Bonfiglioli, D | 1 |
| Pogliaghi, I | 1 |
| Ottomano, C | 1 |
| Fasoli, A | 1 |
| Avogaro, P | 1 |
| Bittolo Bon, G | 1 |
| Belussi, F | 1 |
| Pontoglio, E | 1 |
| Cazzolato, G | 1 |
| Gariot, P | 1 |
| Barrat, E | 1 |
| Mejean, L | 1 |
| Pointel, JP | 1 |
| Drouin, P | 1 |
| Debry, G | 1 |
| Schwartzkopff, W | 2 |
| Luley, C | 2 |
| Scheffler, W | 2 |
| Lehmann-Leo, W | 1 |
| Schilling, A | 2 |
| Wegscheider, K | 1 |
| Kritchevsky, D | 1 |
| Ducobu, J | 1 |
| Calder, D | 1 |
| Canzler, H | 1 |
| Bojanovski, D | 1 |
| Bergemann, R | 1 |
| Brandt, A | 1 |
| Siegrist, W | 1 |
| Ol'binskaia, LI | 1 |
| Vartanova, OA | 1 |
| Aleksandrovskaia, TN | 1 |
| Shaldaeva, VV | 1 |
| Seidehamel, RJ | 1 |
| Goldberg, AC | 1 |
| Schonfeld, G | 1 |
| Feldman, EB | 1 |
| Ginsberg, HN | 1 |
| Hunninghake, DB | 1 |
| Insull, W | 1 |
| Knopp, RH | 1 |
| Kwiterovich, PO | 1 |
| Mellies, MJ | 1 |
| Pickering, J | 1 |
| Karádi, I | 1 |
| Pados, G | 1 |
| Németh-Csóka, M | 1 |
| Romics, L | 1 |
| Reiner, Z | 1 |
| Salzer, B | 1 |
| Kes, P | 1 |
| Brown, WV | 1 |
| Podda, M | 1 |
| Zuin, M | 1 |
| Franceschini, G | 1 |
| Sirtori, M | 1 |
| Gianfranceschi, G | 1 |
| Frosi, T | 1 |
| Montanari, G | 1 |
| Sirtori, CR | 1 |
6 trials available for fenofibrate and Carbohydrate Inducible Hyperlipemia
| Article | Year |
|---|---|
[Effect of lipanthyl on parameters of lipid metabolism in patients with primary hyperlipoproteinemia].
Topics: Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Double-Blind Method; Female; Fenofibrate; H | 1984 |
[Comparison of the hypolipemic effects of bezafibrate and fenofibrate in patients with hyperlipoproteinemia type II and IV].
Topics: Adult; Aged; Bezafibrate; Cholesterol; Clinical Trials as Topic; Female; Fenofibrate; Humans; Hyperl | 1984 |
[Efficacy of bezafibrate and fenofibrate on elevated blood lipids in HLP type IIa, IIb and IV].
Topics: Adult; Aged; Anticholesteremic Agents; Bezafibrate; Clofibrate; Clofibric Acid; Female; Fenofibrate; | 1982 |
Lowering effect of fenofibrate (procetofene) on lipoproteins in different types of hyperlipoproteinemias.
Topics: Cholesterol; Female; Fenofibrate; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type II | 1980 |
Fenofibrate in type IV and type V hyperlipoproteinemia.
Topics: Cholesterol; Double-Blind Method; Female; Fenofibrate; Gastrointestinal Diseases; Humans; Hyperlipop | 1989 |
Fenofibrate for the treatment of type IV and V hyperlipoproteinemias: a double-blind, placebo-controlled multicenter US study.
Topics: Adolescent; Adult; Aged; Cholesterol; Clinical Trials as Topic; Double-Blind Method; Female; Fenofib | 1989 |
17 other studies available for fenofibrate and Carbohydrate Inducible Hyperlipemia
| Article | Year |
|---|---|
Oligo-arthritis and type IV hyperlipoproteinemia.
Topics: Achilles Tendon; Arthritis; Cholesterol; Female; Fenofibrate; Humans; Hyperlipoproteinemia Type IV; | 2009 |
Efficacy and tolerability of a "suprabioavailable" formulation of fenofibrate in patients with dyslipidemia: a pooled analysis of two open-label trials.
Topics: Adolescent; Adult; Aged; Biological Availability; Cholesterol, HDL; Clinical Trials as Topic; Female | 2002 |
Potent capillary isotachophoresis (cITP) for analyzing a marker of coronary heart disease risk and electronegative low-density lipoprotein (LDL) in small dense LDL fraction.
Topics: Biomarkers; Chemical Precipitation; Coronary Disease; Electrophoresis, Capillary; Fenofibrate; Hepar | 2005 |
Fenofibrate therapy of hypertriglyceridaemia. Differential effects on LDL cholesterol level in type IV and in type IIb primary hyperlipoproteinaemia.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Fenofibrate; Humans; Hyperlipoproteinemia Type II; Hyperl | 1984 |
Variations in lipids and proteins of lipoproteins by fenofibrate in some hyperlipoproteinaemic states.
Topics: Adult; Aged; Apolipoproteins; Cholesterol; Diet; Female; Fenofibrate; Humans; Hypercholesterolemia; | 1983 |
Fenofibrate and human liver. Lack of proliferation of peroxisomes.
Topics: Adult; Aged; Cell Division; Diet; Female; Fenofibrate; Humans; Hyperlipoproteinemia Type II; Hyperli | 1983 |
[Pharmacology of fenofibrate (author's transl)].
Topics: Animals; Cholesterol; Clofibrate; Dogs; Dose-Response Relationship, Drug; Fenofibrate; Humans; Hyper | 1980 |
[Effect of phenofibrate on the blood serum lipid level in hyperlipoproteinemias and its comparison with clofibrate].
Topics: Adult; Aged; Cholesterol; Clofibrate; Female; Fenofibrate; Humans; Hyperlipoproteinemia Type II; Hyp | 1980 |
[Clinical study of fenofibrate in hyperlipoproteinemias].
Topics: Adult; Aged; Cholesterol; Female; Fenofibrate; Humans; Hyperlipoproteinemia Type II; Hyperlipoprotei | 1980 |
The effect of etofibrate retard, bezafibrate and procetofen.
Topics: Aged; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Female; Fenofibrate; Humans; Hyperlipopr | 1980 |
Cost-effectiveness study of a lipid-lowering therapy in hyperlipoproteinaemia type IIb and type IV (Frederickson).
Topics: Bezafibrate; Cost-Benefit Analysis; Diabetes Complications; Fenofibrate; Gemfibrozil; Humans; Hyperl | 1993 |
[The clinico-biochemical activity and tolerance of the hypolipidemic preparation lipanthyl].
Topics: Arteriosclerosis; Drug Evaluation; Female; Fenofibrate; Humans; Hyperlipoproteinemia Type II; Hyperl | 1991 |
[The effect of lipanthyl therapy on hyperlipoproteinemia type II/a, II/b and IV].
Topics: Fenofibrate; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Propionates | 1988 |
[Comparison of the effects of fenofibrate administered in doses of 3 x 100mg and 1 x 250mg per day in patients with type IIA, IIB and IV hyperlipoproteinemias].
Topics: Adult; Aged; Female; Fenofibrate; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV | 1988 |
Potential use of fenofibrate and other fibric acid derivatives in the clinic.
Topics: Clofibrate; Fenofibrate; Humans; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type II; Hy | 1987 |
Effects of fenofibrate on biliary lipids and bile acid pool size in patients with type IV hyperlipoproteinemia.
Topics: Adult; Aged; Bile; Bile Acids and Salts; Cholelithiasis; Cholesterol; Female; Fenofibrate; Humans; H | 1985 |
Reversible increase of the apo CII/apo CIII-1 ratio in the very low density lipoproteins after procetofen treatment in hypertriglyceridemic patients.
Topics: Adult; Aged; Apolipoprotein C-II; Apolipoprotein C-III; Apolipoproteins C; Cholesterol, HDL; Cholest | 1985 |